iMedConsent™ Application Achieves ONC-ATCB 2011/2012 EHR Certification from ICSA Labs
14 Fevereiro 2013 - 12:00PM
Business Wire
Dialog Medical, a subsidiary of Standard Register (NYSE:SR),
reported today that its iMedConsent application has achieved 2011
Edition EHR Modular* Inpatient ONC-ACB Certification, which
designates that the software is capable of supporting providers
with Stage 1 meaningful use measures required to qualify for
funding under the American Recovery and Reinvestment Act (ARRA).
The iMedConsent application was certified on January 31, 2013 under
ICSA Labs’ ONC-ACB Electronic Health Record program and is
compliant in accordance with the criteria adopted by the Secretary
of Health and Human Services.
“Securing ONC-ACB Certification demonstrates a commitment to
supporting hospitals’ meaningful use initiatives,” said Tim Kelly,
vice president of marketing for Dialog Medical. “Certification in
five inpatient domain criteria is essential to the attestation
needs of our current and prospective clients.”
“Standard Register Healthcare is committed to advancing the
patient engagement strategies of hospitals and providers,” said
John King, president of Standard Register Healthcare. “Receipt of
ONC-ACB Certification of the iMedConsent application punctuates our
commitment to supporting patient-centered communications in
hospitals seeking funding for their EHR investment under the
ARRA.”
ICSA Labs, an independent division of Verizon, offers
vendor-neutral testing and certification. Its electronic health
record certification and testing program provides verification that
the certified EHR technology supports meaningful use, as well as
helps health care organizations protect sensitive and private
patient information.
iMedConsent application version 3.833 meets the following
certification criteria:
- 170.302(g) Smoking Status
- 170.302(m) Patient Specific Education
Resources
- 170.306(b) Record Demographics
- 170.306(e) Electronic Copy of Discharge
Instructions
- 170.306(h) Advance Directives
- 170.302(o) Access Control
- 170.302(p) Emergency Access
- 170.302(q) Automatic Log-off
- 170.302(r) Audit Log
- 170.302(s) Integrity
- 170.302(t) Authentication
- 170.302(u) General Encryption
- 170.302(v) Encryption When Exchanging
Electronic Health Information
The additional software relied upon to comply with one or more
of the certification criteria included Microsoft SQL Server
2008.
The iMedConsent application will be showcased by Standard
Register Healthcare and Dialog Medical at the HIMSS13 Annual
Conference and Exhibition in booth 1117.
About Dialog Medical
Dialog Medical, a Standard Register Healthcare company, is the
leading provider of patient engagement solutions including tools
for supporting the informed consent process as well as the
provision of pre- and post-procedure instructions and patient
education materials. The company’s iMedConsent™ application is
currently used by more than 15,000 physicians and in more than 200
hospitals nationwide. More information on Dialog Medical and its
products is available at www.dialogmedical.com. For additional
information on the 2011 Edition EHR Modular* Inpatient ONC-ACB
Certification of the iMedConsent application version 3.833, visit
www.dialogmedical.com/meaningful_use/
About Standard Register
Standard Register (NYSE:SR), celebrating 100 years of
innovation, is trusted by the world’s leading companies to advance
their reputations by aligning their communications with corporate
standards and priorities. Providing market-specific insights and a
compelling portfolio of solutions to address the changing business
landscape in commercial, healthcare, financial services and
industrial markets, Standard Register is the recognized leader in
the management and execution of mission-critical communications.
More information is available at www.standardregister.com.
Standard Register Healthcare is a business unit of Standard
Register, serving more than 3,100 clients from across the
healthcare delivery network, including acute, ambulatory, and
long-term care, managed care and the suppliers that support them. A
recognized leader in managing critical information and
communications, Standard Register Healthcare, together with Dialog
Medical, a subsidiary of Standard Register, provides
industry-leading technology, solutions and services to accelerate
performance, attract and educate patients, enhance safety and
support patient-centered care. More information is available at
www.standardregister.com/healthcare.
About ICSA Labs
ICSA Labs, an independent division of Verizon, offers
third-party testing and certification of security and health IT
products, as well as network-connected devices, to measure product
compliance, reliability and performance for many of the world’s top
security vendors. ICSA Labs is an ISO/IEC 17025:2005 accredited and
9001:2008 registered organization. Visit http://www.icsalabs.com
and http://www.icsalabs.com/blogs for more information.
* This EHR Module is 2011 Edition compliant and has been
certified by an ONC-ACB in accordance with the applicable
certification criteria adopted by the Secretary of Health and Human
Services. This certification does not represent an endorsement by
the U.S. Department of Health and Human Services or guarantee the
receipt of incentive payments. iMedConsent™ Application, Version
3.833 was certified on January 31, 2013. CHPL Product Number:
130003R00
Spire (NYSE:SR)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Spire (NYSE:SR)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024